{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:25:30Z","timestamp":1791962730389,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007613","name":"Ankara Universitesi","doi-asserted-by":"publisher","award":["BAP-21B0237004"],"award-info":[{"award-number":["BAP-21B0237004"]}],"id":[{"id":"10.13039\/100007613","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.bioorg.2024.107429","type":"journal-article","created":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T21:34:41Z","timestamp":1714944881000},"page":"107429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Synthesis of novel indol-3-acetamido analogues as potent anticancer agents, biological evaluation and molecular modeling studies"],"prefix":"10.1016","volume":"148","author":[{"given":"Fatima","family":"Doganc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulin","family":"Ozkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazila","family":"Farhangzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Acelya","family":"Mavideniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuman","family":"Sunguroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"G\u00f6ker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.107429_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.fsisyn.2020.11.003","article-title":"United Nations Office on Drugs and Crime: Recommended methods for the identification and analysis of synthetic cannabinoid receptor agonists in seized materials","volume":"3","author":"Tettey","year":"2021","journal-title":"Forensic Sci. Int. Synergy."},{"key":"10.1016\/j.bioorg.2024.107429_b0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/1874467212666190215112036","article-title":"New insights in cannabinoid receptor structure and signaling","volume":"12","author":"Ye","year":"2019","journal-title":"Curr. Mol. Pharm."},{"key":"10.1016\/j.bioorg.2024.107429_b0015","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1021\/acs.chemrev.5b00411","article-title":"Medicinal chemistry, pharmacology, and potential therapeutic benefits of cannabinoid CB2 receptor agonists","volume":"116","author":"Tabrizi","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2024.107429_b0020","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1021\/acschemneuro.5b00112","article-title":"Pharmacology of indole and indazole synthetic cannabinoid designer drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADBPINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA","volume":"6","author":"Banister","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2024.107429_b0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11419-015-0297-2","article-title":"Four types of cannabimimetic indazole and indole derivatives, ADB-BINACA, AB-FUBICA, ADB-FUBICA, and AB-BICA, identified as new psychoactive substances","volume":"34","author":"Qian","year":"2016","journal-title":"Forensic Toxicol."},{"issue":"55","key":"10.1016\/j.bioorg.2024.107429_b0030","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/jnci\/55.3.597","article-title":"Antineoplastic activity of cannabinoids","volume":"I","author":"Munson","year":"1975","journal-title":"J. Natl. Cancer"},{"key":"10.1016\/j.bioorg.2024.107429_b0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3747\/co.23.3080","article-title":"Anticancer mechanisms of cannabinoids","volume":"23","author":"Velasco","year":"2016","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.bioorg.2024.107429_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41416-022-01727-4","article-title":"Cannabinoids as anticancer drugs: Current status of preclinical research","volume":"127","author":"Hinz","year":"2022","journal-title":"Brit. J. Cancer"},{"key":"10.1016\/j.bioorg.2024.107429_b0045","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/15384101.2020.1742952","article-title":"Cannabinoids as anticancer therapeutic agents","volume":"19","author":"Kovalchuk","year":"2020","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bioorg.2024.107429_b0050","doi-asserted-by":"crossref","first-page":"14448","DOI":"10.1021\/acs.jmedchem.0c01357","article-title":"Cannabinoid receptor subtype 2 (CB2R) in a multitarget approach: Perspective of an innovative strategy in cancer and neurodegeneration","volume":"63","author":"Mangiatordi","year":"2020","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107429_b0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.17305\/bjbms.2018.3532","article-title":"Cannabinoids in cancer treatment: Therapeutic potential and legislation","volume":"19","author":"Daris","year":"2019","journal-title":"Bosn. J. Basic Med. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107429_b0060","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.canlet.2009.04.005","article-title":"Cannabinoids in the treatment of cancer","volume":"285","author":"Alexander","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2024.107429_b0065","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/bph.14426","article-title":"Anti-tumour actions of cannabinoids","volume":"176","author":"Hinz","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2024.107429_b0070","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1476-5381.2012.02050.x","article-title":"Cannabidiol inhibits angiogenesis by multiple mechanisms","volume":"167","author":"Solinas","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2024.107429_b0075","doi-asserted-by":"crossref","first-page":"e23901","DOI":"10.1371\/journal.pone.0023901","article-title":"Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion","volume":"6","author":"Nasser","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107429_b0080","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1071\/CH21006","article-title":"The chemistry of cannabis and cannabinoids","volume":"74","author":"Duggan","year":"2021","journal-title":"Aust. J. Chem."},{"issue":"22","key":"10.1016\/j.bioorg.2024.107429_b0085","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.3390\/cancers13225701","article-title":"The endocannabinoid system as a pharmacological target for new cancer therapies","volume":"13","author":"Ramer","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2024.107429_b0090","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.lfs.2010.02.014","article-title":"A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss","volume":"86","author":"Lozano","year":"2010","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107429_b0095","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1021\/jm301527r","article-title":"Design, synthesis, and pharmacological properties of new heteroarylpyridine\/heteroarylpyrimidine derivatives as CB2 cannabinoid receptor partial agonists","volume":"56","author":"Tabrizi","year":"2013","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2024.107429_b0100","doi-asserted-by":"crossref","first-page":"6190","DOI":"10.3390\/molecules26206190","article-title":"The spicy story of cannabimimetic indoles","volume":"26","author":"Howlett","year":"2021","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.bioorg.2024.107429_b0105","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.3390\/ijms22073680","article-title":"Molecular mechanism of cannabinoids in cancer progression","volume":"22","author":"Pagano","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107429_b0110","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/dta.3185","article-title":"Identification of AD-18, 5F-MDA-19, and pentyl MDA-19 in seized materials after the class-wide ban of synthetic cannabinoids in China","volume":"14","author":"Liu","year":"2021","journal-title":"Drug Test Anal."},{"issue":"8","key":"10.1016\/j.bioorg.2024.107429_b0115","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1021\/acschemneuro.9b00696","article-title":"Prediction of the binding affinities and selectivity for CB1 and CB2 ligands using homology modeling, molecular docking, molecular dynamics simulations, and MM-PBSA binding free energy calculations","volume":"11","author":"Ji","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2024.107429_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2023.108620","article-title":"Influence of structural characteristics on the binding of synthetic cannabinoids from the JWH family to the CB1 receptor: A computational study","volume":"126","author":"Chaturvedi","year":"2024","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.bioorg.2024.107429_b0125","doi-asserted-by":"crossref","unstructured":"A.S. Gurkan, A.Z. Karabay, Z. Buyukbingol, E. Buyukbingol, Synthesis and effects of some novel tetrahydronaphthalene derivatives on proliferation and nitric oxide production in lipopolysaccharide activated Raw 264.7 macrophages, Eur. J. Med. Chem. 46(2) (2011) 468-479. https:\/\/doi.org\/10.1016\/j.ejmech.2010.11.021.","DOI":"10.1016\/j.ejmech.2010.11.021"},{"key":"10.1016\/j.bioorg.2024.107429_b0130","doi-asserted-by":"crossref","unstructured":"A.Z. Karabay, A. Koc, T. Ozkan, Y. Hekmatshoar, B. Altinok Gunes, A. Sunguroglu, Z. Buyukbingol, A. Atalay, F. Aktan, Expression analysis of Akirin-2, NF\u03baB-p65 and \u03b2-catenin proteins in imatinib resistance of chronic myeloid leukemia, Hematology 23(10) (2018) 765-770. https:\/\/doi.org\/10.1080\/10245332.2018.1488795.","DOI":"10.1080\/10245332.2018.1488795"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107429_b0135","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s11033-021-06141-2","article-title":"Cytotoxic effect of 6-Shogaol in Imatinib sensitive and resistant K562 cells","volume":"48","author":"Ozkan","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bioorg.2024.107429_b0140","doi-asserted-by":"crossref","unstructured":"Y. Hekmatshoar, T. Ozkan, B. Altinok Gunes, S. Bozkurt, A. Karadag, A.Z. Karabay, A. Sunguroglu, Characterization of imatinib-resistant K562 cell line displaying resistance mechanisms, Cell. Mol. Biol. 64(6) (2018) 23-30. http:\/\/dx.doi.org\/10.14715\/cmb\/2018.64.6.5.","DOI":"10.14715\/cmb\/2018.64.6.5"},{"key":"10.1016\/j.bioorg.2024.107429_b0145","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nprot.2007.30","article-title":"In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro","volume":"2","author":"Liang","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bioorg.2024.107429_b0150","doi-asserted-by":"crossref","first-page":"11468","DOI":"10.1038\/s41598-023-38692-8","article-title":"Natural resveratrol analogs differentially target endometriotic cells into apoptosis pathways","volume":"13","author":"Go\u0142\u0105bek-Grenda","year":"2023","journal-title":"Sci. Rep."},{"issue":"14","key":"10.1016\/j.bioorg.2024.107429_b0155","first-page":"1924","article-title":"Apoptotic effects of some tetrahydronaphthalene derivatives on K562 human chronic myelogenous leukemia cell line","volume":"17","author":"Koc","year":"2017","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107429_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2021.106523","article-title":"Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells","volume":"102","author":"Ozkan","year":"2021","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bioorg.2024.107429_b0165","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejmech.2012.03.006","article-title":"Design, synthesis and biological evaluation of thiazole- and indole-based derivatives for the treatment of type II diabetes","volume":"52","author":"Xu","year":"2012","journal-title":"Eur. J. Med. Chem."},{"issue":"127452","key":"10.1016\/j.bioorg.2024.107429_b0170","first-page":"A1","article-title":"5-Oxo-ete receptor antagonist compounds","volume":"2010","author":"Powell","year":"2010","journal-title":"WO"},{"issue":"7664","key":"10.1016\/j.bioorg.2024.107429_b0175","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nature23272","article-title":"Crystal structures of agonist-bound human cannabinoid receptor CB1","volume":"547","author":"Hua","year":"2017","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107429_b0180","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.cell.2020.01.008","article-title":"Activation and signaling mechanism revealed by cannabinoid receptor-Gi complex structures","volume":"180","author":"Hua","year":"2020","journal-title":"Cell"},{"issue":"21","key":"10.1016\/j.bioorg.2024.107429_b0185","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"issue":"W1","key":"10.1016\/j.bioorg.2024.107429_b0190","doi-asserted-by":"crossref","first-page":"W530","DOI":"10.1093\/nar\/gkab294","article-title":"PLIP 2021: Expanding the scope of the protein-ligand interaction profiler to DNA and RNA","volume":"49","author":"Adasme","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2024.107429_b0195","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"8","key":"10.1016\/j.bioorg.2024.107429_b0200","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/prot.22711","article-title":"Improved side-chain torsion potentials for the Amber ff99SB protein force field","volume":"78","author":"Lindorff-Larsen","year":"2010","journal-title":"Proteins"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824003341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824003341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T19:15:26Z","timestamp":1717614926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824003341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":40,"alternative-id":["S0045206824003341"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107429","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of novel indol-3-acetamido analogues as potent anticancer agents, biological evaluation and molecular modeling studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107429"}}